Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
Oncology|November 28, 2021
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA StudyGiuseppe Di Lorenzo, Mario Iervolino, Ferdinando Primiano, et al.
World Journal of Urology|December 7, 2018
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trialsMatteo Ferro, Giuseppe Di Lorenzo, Ottavio de Cobelli, et al.
Genes|July 2, 2021
The TNFRSF13C H159Y Variant Is Associated with Severe COVID-19: A Retrospective Study of 500 Patients from Southern ItalyRoberta Russo, Immacolata Andolfo, Vito Alessandro Lasorsa, et al.
Future Oncology (London, England)|September 19, 2015
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancerOttavio De Cobelli, Carlo Buonerba, Daniela Terracciano, et al.
Medicine|November 19, 2015
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell CarcinomaGiuseppe Lucarelli, Monica Rutigliano, Francesca Sanguedolce, et al.
Frontiers in Pharmacology|April 5, 2018
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I TrialCarlo Buonerba, Pietro De Placido, Dario Bruzzese, et al.
Journal of Cancer|September 21, 2017
The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate CancerCarlo Buonerba, Guru Sonpavde, Francesca Vitrone, et al.
Iscience|March 22, 2021
Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19Immacolata Andolfo, Roberta Russo, Vito Alessandro Lasorsa, et al.
Critical Reviews in Oncology/Hematology|December 14, 2020
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findingsMatteo Ferro, Giuseppe Lucarelli, Felice Crocetto, et al.
Critical Reviews in Oncology/Hematology|June 23, 2023
Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors aloneFelice Crocetto, Matteo Ferro, Carlo Buonerba, et al.
Pageof 16